---
figid: PMC9535628__or-48-05-08410-g07
pmcid: PMC9535628
image_filename: or-48-05-08410-g07.jpg
figure_link: /pmc/articles/PMC9535628/figure/f8-or-48-05-08410/
number: Figure 8
figure_title: ''
caption: Effect of circ_0026652 knockdown on multiple myeloma chemosensitivity to
  bortezomib. (A) circ_0026652 expression, (B) relative cell viability under different
  bortezomib treatment (0, 1, 2, 4, 8 and 16 nM) and (C and D) cell apoptosis under
  4 nM bortezomib treatment in U266 cells transfected with si-circ and si-NC. (E)
  circ_0026652 expression, (F) relative cell viability under different bortezomib
  concentrations (0, 0.25, 0.5, 1, 2 and 4 nM) and (G and H) cell apoptosis under
  1 nM bortezomib treatment in RPMI-8226 cells transfected with si-circ and si-NC.
  *P<0.05, **P<0.01, ***P<0.001. circ, circular RNA; si, small interfering RNA; NC,
  negative control.
article_title: Dysregulated circular RNAs are closely linked to multiple myeloma prognosis,
  with circ_0026652 predicting bortezomib-based treatment response and survival via
  the microRNA-608-mediated Wnt/Î²-catenin pathway.
citation: Lu Li, et al. Oncol Rep. 2022 Nov;48(5):195.
year: '2022'

doi: 10.3892/or.2022.8410
journal_title: Oncology Reports
journal_nlm_ta: Oncol Rep
publisher_name: D.A. Spandidos

keywords:
- multiple myeloma
- circular RNA profiles
- circular RNA 0026652
- prognosis
- chemosensitivity to bortezomib

---
